According to a recent LinkedIn post from LeanTaaS, the company plans to participate in the Becker’s Healthcare Oncology Executive Summit in Chicago on April 13–14. The post highlights a featured session led by Marisa Quinn of UCSF Health focused on “UCSF Health’s Journey in AI-Driven Infusion Operational Efficiency,” showcasing use of the iQueue for Infusion Centers platform.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post suggests that LeanTaaS is positioning its iQueue solution as a tool for cancer centers to improve access, balance workloads, and optimize infusion operations. For investors, this visibility at a specialized oncology leadership forum may support lead generation among large health systems and reinforce LeanTaaS’s role in AI-enabled operational efficiency, potentially driving longer-term demand and deepening relationships in the oncology care segment.
The post also indicates that LeanTaaS will have a presence on the exhibition floor at booth #232, which could facilitate direct engagement with decision-makers in oncology and infusion services. While no financial metrics or new contracts are mentioned, ongoing participation in targeted industry summits may contribute to pipeline development and brand positioning in the competitive healthcare operations and AI-in-healthcare market.